Education
About Us
Working with TipRanks
Follow Us
Quanterix Corporation (QTRX)
NASDAQ:QTRX
Earnings Data
Report Date
May 12, 2026After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.47Last Year’s EPS
-0.53Same Quarter Last Year
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call presented a mixed picture: GAAP revenue growth (+25% YoY), meaningful diagnostic milestones (CMS reimbursement and FDA 510(k) submission), product launches, margin improvement, synergy realization and a strong cash position are positive signs. However, significant organic revenue declines (-22% overall; Simoa -22%; Spatial -23%/ -16% ex-agreement), soft pharma demand (-21%), a dilutive terminated agreement and continued adjusted EBITDA losses highlight material near-term challenges. Management emphasized synergy delivery, improved cash usage and an expectation of cash-flow breakeven in H2 2026, but pro forma top-line growth guidance is modest (~+2% at midpoint) and execution against diagnostic commercialization and market recovery remains critical.Company Guidance
Quarterly Revenue Growth (GAAP)
Total revenue for Q4 was $43.9 million, up 25% year-over-year and up 7% sequentially, driven in part by acquisitions and release of pent-up demand from academic customers.
Diagnostics Partnerships and Revenue Growth
Diagnostics partnerships grew to 25 partnerships that generated $9.6 million in revenue in 2025 versus $6.0 million in the prior year (approximately +60% year-over-year), expanding the Diagnostics revenue base.
LucentAD Regulatory and Reimbursement Milestones
LucentAD achieved a CMS reimbursement crosswalk establishing a reference price of $897 and a 510(k) submission to the FDA was filed in January 2026; management expects FDA review in ~6–9 months, supporting future commercial rollout.
Product Innovation and Assay Launches
Launched 13 new assays in 2025 (including two new Simoa Tau assays, pTau-205 and pTau-212) with strong initial interest; management expects a regular cadence of assay launches quarterly through 2026.
Gross Margin and Non-GAAP Profitability Improvements
Q4 GAAP gross margin was 45.7% (gross profit $20.0M); non-GAAP gross margin was 50% (non-GAAP gross profit $21.9M). Non-GAAP operating expenses decreased to $37.0M and adjusted EBITDA improved to a loss of $7.9M (a sequential improvement of $4.0M vs Q3).
Synergy Realization and Cost Discipline
Implemented $74 million of an $85 million cost synergy target and on track to achieve the full target by end of Q1, contributing to sequential operating expense reductions and improved cash usage.
Strong Cash Position and Improved Cash Usage
Ended Q4 with $122 million in cash, equivalents and marketable securities; adjusted cash usage improved to $3.0M in the quarter versus $16.1M in Q3, and the company expects to reach cash-flow breakeven in H2 2026 and end the year with approximately $100M cash and no debt.
Instrument Placements and Consumables Momentum
Placed 21 Simoa and 17 Spatial instruments in the quarter (versus 18 Simoa in Q4 2024); consumables revenue was $23.0M and increased $3.8M sequentially (Simoa $15.4M, Spatial $7.6M), supporting recurring revenue streams.
QTRX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
QTRX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 02, 2026 | $6.33 | ― | ― |
Nov 10, 2025 | $5.12 | $5.00 | -2.34% |
Aug 07, 2025 | $5.51 | $4.75 | -13.79% |
May 12, 2025 | $5.73 | $4.64 | -19.02% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Quanterix Corporation (QTRX) report earnings?
Quanterix Corporation (QTRX) is schdueled to report earning on May 12, 2026, After Close (Confirmed).
What is Quanterix Corporation (QTRX) earnings time?
Quanterix Corporation (QTRX) earnings time is at May 12, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is QTRX EPS forecast?
QTRX EPS forecast for the fiscal quarter 2026 (Q1) is -0.47.